Entheogenic Use of Cannabis - Wikipedia, the Free Encyclopedia Entheogenic Use of Cannabis from Wikipedia, the Free Encyclopedia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2012 St. Peter's Pikeland Ucc Church History
2012 Author Unknown The wonder of it! Eternity having been set in the tiny acorn of the man called Jesus Christ, waiting to fill the universe with the plantation of mighty Live-oak trees! ST. PETER’S PIKELAND UCC CHURCH HISTORY CHAPTER THREE 1883 THROUGH 2012 When recounting our history – particularly during the latter part of the 20th and the beginning of the 21st centuries – we must recognize and commend the work of our St. Peter’s Angel, Annamae Moore. Officially we call her our Pastoral Coordinator, a role that in many ways only Annamae is uniquely qualified to serve. Our last eight pastors (Siudy, Thompson, Mackey, Langerhans, Hetrich, Lamson, Zehmer and Hanson) have been ably assisted by Annamae. She has an extraordinary bedside manner when calling on the sick or grieving families, she helps every bride with the stress of a wedding day and every Sunday assure that our worship service runs like a finely tuned watch. We thank Annamae for her tireless service and dedicate this chapter of our history to her because she has been and continues to be a major part of our church life. 2 Table of Contents A Message to Our Successors at St. Peters ..................................................................................... 5 Getting to Know St. Peter’s Pikeland in the Larger Context of the United Church of Christ ......... 7 What we believe ......................................................................................................................... 7 UCC Structure:............................................................................................................................ -
In the United States District Court
Case 1:10-cr-00384-LEK Document 811 Filed 12/30/13 Page 1 of 29 PageID #: <pageID> IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF HAWAII UNITED STATES OF AMERICA, ) CR. NO. 10-00384(01) LEK ) Plaintiff, ) ) vs. ) ) ROGER CUSICK CHRISTIE (01), ) et al., ) ) Defendants. ) _____________________________ ) ORDER DENYING DEFENDANTS’ MOTION IN LIMINE TO PRESENT RELIGIOUS FREEDOM RESTORATION ACT DEFENSE On April 1, 2013, Defendants Roger Cusick Christie (“Christie”) and Sherryanne L. Christie, formerly known as Sherryanne L. St. Cyr (“St. Cyr”, both collectively “Defendants”), filed their joint Motion in Limine to Present Religious Freedom Restoration Act Defense (“Motion in Limine”).1 [Dkt. no. 587.] Plaintiff the United States of America (“the Government”) filed its memorandum in opposition on May 20, 2013,2 and Defendants filed their joint reply on July 8, 2013.3 [Dkt. 1 Defendants filed an Errata to the Motion in Limine on April 19, 2013. [Dkt. no. 595.] 2 The Government filed an Errata to its memorandum in opposition on June 3, 2013. [Dkt. no. 612.] The Government also submitted additional exhibits on June 3, 2013, [dkt. no. 613 (website excerpts); dkt. nos. 614-17 (transcripts of selected recorded conversations),] and on July 8, 2013 [dkt. no. 640 (select photographs of “Sanctuary Kit”)]. 3 Defendants filed the Supplemental Declaration of Roger Christie on July 16, 2013. [Dkt. no. 664.] Case 1:10-cr-00384-LEK Document 811 Filed 12/30/13 Page 2 of 29 PageID #: <pageID> nos. 603, 637.] On July 29, 2013, this Court heard oral argument on a preliminary issue related to the Motion in Limine, and this Court gave the parties an outline of its ruling on the preliminary issue on July 31, 2013.4 After receiving additional exhibits,5 this Court held an evidentiary hearing on the Motion in Limine on August 27, 2013. -
Low-THC Cannabis Products in Europe
Low-THC cannabis products in Europe December 2020 Legal notice This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is protected by copyright. The EMCDDA accepts no responsibility or liability for any consequences arising from the use of the data contained in this document. The contents of this publication do not necessarily reflect the official opinions of the EMCDDA’s partners, any EU Member State or any agency or institution of the European Union. Manuscript completed in December 2020 Luxembourg: Publications Office of the European Union, 2020 © European Monitoring Centre for Drugs and Drug Addiction, 2020 Reproduction is authorised provided the source is acknowledged. Credits for cover photos: Envato (first and third photos, left to right), Brendan Hughes (other photos). For any use or reproduction of photos or other material that is not under the EMCDDA copyright, permission must be sought directly from the copyright holders. Print ISBN 978-92-9497-555-3 doi:10.2810/593551 TD-03-20-749-EN-C PDF ISBN 978-92-9497-554-6 doi:10.2810/69625 TD-03-20-749-EN-N Recommended citation: European Monitoring Centre for Drugs and Drug Addiction (2020), Low-THC cannabis products in Europe, Publications Office of the European Union, Luxembourg. YEARS OF MONITORING 1995–2020 Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal Tel. +351 211210200 [email protected] I www.emcdda.europa.eu twitter.com/emcdda I facebook.com/emcdda I Contents 4 Introduction and rationale 4 I What are low-THC cannabis products? -
HEMP VS. MARIJUANA: the FEDERAL BATTLE to CONTROL the MEANING of CANNABIS Carrie Lynn Torrella Submitted to the Faculty of the U
HEMP VS. MARIJUANA: THE FEDERAL BATTLE TO CONTROL THE MEANING OF CANNABIS Carrie Lynn Torrella Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Master of Arts in the Department of History, Indiana University December 2011 Accepted by the Faculty of Indiana University, in partial fulfillment of the requirements for the degree of Master of Arts. ________________________________ Michael David Snodgrass, Ph.D., Chair Master’s Thesis Committee ______________________________ Robert G. Barrows, Ph.D. ______________________________ Nancy Marie Robertson, Ph.D. ii ACKNOWLEDGMENTS I would like to express my thanks to all the people who helped me complete this project. The staff at both the Advertising Council Archives at the University of Illinois at Urbana-Champaign and the Harry J. Anslinger Papers at Penn State Special Collections Library assisted my research. My thesis committee members, Dr. Nancy Robertson and Dr. Robert Barrows, offered me valuable insight and suggestions for improvements. My thesis chair, Dr. Michael Snodgrass, has patiently read chapter drafts and given me thoughtful comments and suggestions. My parents, Marlene and Renè Torrella, have given me unconditional love and limitless support and prodded me to complete this project. I would also like to thank my sisters Tracy and Abigail, my brother Andrew and my dear friends Jesica, Anne, Veda, and Will for their support. Most of all, I would like to thank my daughters Claudia and Natasha for giving me the motivation -
A Survey of Cannabis Consumption and Implications of an Experimental Policy Manipulation Among Young Adults
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2018 A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS Alyssa K. Rudy Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd © The Author Downloaded from https://scholarscompass.vcu.edu/etd/5297 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS A thesis proposal submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Alyssa Rudy B.S., University of Wisconsin - Whitewater, 2014 Director: Dr. Caroline Cobb Assistant Professor Department of Psychology Virginia Commonwealth University Richmond, Virginia January, 2018 ii Acknowledgement I would like to first acknowledge Dr. Caroline Cobb for your guidance and support on this project. Thank you for allowing me to explore my passions. I am thankful for your willingness to jump into an unfamiliar area of research with me, and thank you for constantly pushing me to be a better writer, researcher, and person. I would also like to acknowledge the other members of my thesis committee, Drs. Eric Benotsch and Andrew Barnes for their support and expertise on this project. I would also like to thank my family for always supporting my desire to pursue my educational and personal goals. -
TESTIMONY on SENATE BILL (SB) 2402 RELATING to CONTROLLED SUBSTANCES by Ted Sakai, Director Department of Public Safety
NEIL ABERCROMBIE TED SAKAI GOVERNOR DIRECTOR Mlll1b.1lToroey D~Uty Direaor of AdminisbiitiOll , ';.r·. STATE· OF HAWAII Shawn Tsuha DEPARTMENT OF PUBLIC SAFETY Deputy DireclOl" 919Ala Moana Blvd. AM4tl0 La,w En1orttmen1 Honolulu, Hawaii 96813 No. ______ TESTIMONY ON SENATE BILL (SB) 2402 RELATING TO CONTROLLED SUBSTANCES By Ted Sakai, Director Department of Public Safety Senate Committee on Public Safety, Intergovernmental and Military Affairs Senator Will Espero, Chair Senator Rosaiyn H. Baker, Vice Chair Thursday, February 13, 2014 at 2:50 PM State Capitol, Conference Room 224 Chair Espero, Vice Chair Baker, and Members of the Committee: The Department of Public Safety supports SB 2402 which proposes to amend the definition of "marijuana" and "usable marijuana," and "adds a new definition of "hashish" and "marijuana concentrate" to be consistent throughout the Hawaii Revised Statutes. SB 2402 is necessary due to the fact that there is no clear definition of "hashish" in the Hawaii Revised Statutes. Law enforcement and the courts have had to fall back on the Federal definition of "hashish" for laboratory analysis purposes and prior case notes (Stale vs. Choy) that set forth the difference between "marijuana" and "marijuana concentrate" in the courts. SB 2402 if passed will clearly define the difference between the terms "marijuana," "marijuana concentrate," and "hashish." Thank you for the opportunity to testify on this matter. Alissa Gino LMHC, CSAC LATE TEST! MONY Licensed Mental Health Counselor (Hawai'i License #239) Certified Substance Abuse Counselor 1154 Fort St. Mall #206 Honolulu, HI 96813 Cell: (808) 375.9867 Fax: (808) 528.1184 To: Whom it may concern Re: Oppose Bill SB 2402 Date: 13 February 2014 This letter is being written in an attempt to express my opposition of Bill SB 2402. -
Low-THC Cannabis Products in Europe
Low-THC cannabis products in Europe December 2020 Legal notice This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is protected by copyright. The EMCDDA accepts no responsibility or liability for any consequences arising from the use of the data contained in this document. The contents of this publication do not necessarily reflect the official opinions of the EMCDDA’s partners, any EU Member State or any agency or institution of the European Union. Manuscript completed in December 2020 Luxembourg: Publications Office of the European Union, 2020 © European Monitoring Centre for Drugs and Drug Addiction, 2020 Reproduction is authorised provided the source is acknowledged. Credits for cover photos: Envato (first and third photos, left to right), Brendan Hughes (other photos). For any use or reproduction of photos or other material that is not under the EMCDDA copyright, permission must be sought directly from the copyright holders. Print ISBN 978-92-9497-555-3 doi:10.2810/593551 TD-03-20-749-EN-C PDF ISBN 978-92-9497-554-6 doi:10.2810/69625 TD-03-20-749-EN-N Recommended citation: European Monitoring Centre for Drugs and Drug Addiction (2020), Low-THC cannabis products in Europe, Publications Office of the European Union, Luxembourg. YEARS OF MONITORING 1995–2020 Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal Tel. +351 211210200 [email protected] I www.emcdda.europa.eu twitter.com/emcdda I facebook.com/emcdda I Contents 4 Introduction and rationale 4 I What are low-THC cannabis products? -
Lok Sabha Debates
Wednesday, April 26, 1978 r n . s i . v A a . - K . t f Vaisakha 6, 1990 (Saka) LOK SABHA DEBATES ■■V . j),- 1 r'7 t ""S (Fourth Session) s A 7HI*M 33* (Val XIV contains Nos. 41—50) LOK SABHA SECRETARIAT NEW DELHI Price', Rs'4.00 CON TENTS No. 44, Wednesday, April 36, ipySfVaisakha 6 , 1900 (Saka) Columns OraJ Answers to Questions : ^Starred Qustions Nos. 865, 868 to 870, 872, 876, 879, 881 and 883. 1— 34 Written Answers to Questions : Sta 'red Questions Nos. 864, 866, 867, 871, 873 to 875, 877, 878, ■ 880 and 882.........................................................................35— 45 Unstirred Questions Nos. 8120 to 8193, 8195 to 8262, 8264 to 8298 and 8300 to 8319. .... 45— 230 Matters Under Rule 377— (i) Reported hunger strike by casual workers of LIC Calcutta. Prof. Dilip C h a k r a v a r t y ................................................230— 32 (ii) Reported decision of Bengal Immunity Ltd. Calcutta to close its factories and sales offices. Shri Jyotirmoy Bosu 232 (iii) Reported smuggling of Hashish, Charas, Opium etc. Shri S. R. Damani 232— 33 (iv) Reported AIR Broadcast alleging ticketless travel by some Congress (I) workers on 6-4-78. Shri Vasant S a t h e .........................................................233— 34 Papers laid on the T a b l e ...................................................................235— 37 Re. Business of the H o u s e ...................................................................238— 39 Committee on Public Undertakings— Ninth Report..................................................................................................239 Committee on Subordinate Legslation— Eighth R e p o r t .......................................................................................240 Committee on the Welfare of Scheduled Castes and Scheduled Tribes— Nineteenth and Twentieth R e p o r t s ...............................................240 Committee on Private Members’ Bill and Resolution— Eighteenth Report ............................................... -
Phytochemicals in the Control of Human Appetite and Body Weight
Pharmaceuticals 2010, 3, 748-763; doi:10.3390/ph3030748 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Phytochemicals in the Control of Human Appetite and Body Weight Sonia A. Tucci Kissileff Laboratory for the Study of Human Ingestive Behaviour, School of Psychology, University of Liverpool, Eleanor Rathbone Building, Bedford Street South, Liverpool L69 7ZA, UK; E-Mail: [email protected]; Tel.: +44-151-794-1121; Fax: +44-151-794-2945 Received: 9 December 2009; in revised form: 10 March 2010 / Accepted: 19 March 2010 / Published: 22 March 2010 Abstract: Since obesity has grown to epidemic proportions, its effective management is a very important clinical issue. Despite the great amount of scientific effort that has been put into understanding the mechanisms that lead to overconsumption and overweight, at the moment very few approaches to weight management are effective in the long term. On the other hand, modern society is also affected by the growing incidence of eating disorders on the other side of the spectrum such as anorexia and bulimia nervosa which are equally difficult to treat. This review will try to summarise the main findings available in the literature regarding the effect of plants or plant extracts (phytochemicals) on human appetite and body weight. The majority of plant extracts are not single compounds but rather a mixture of different molecules, therefore their mechanism of action usually targets several systems. In addition, since some cellular receptors tend to be widely distributed, sometimes a single molecule can have a widespread effect. This review will attempt to describe the main phytochemicals that have been suggested to affect the homeostatic mechanisms that influence intake and body weight. -
The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM 3 The Rise and Decline of Cannabis Prohibition Authors Dave Bewley-Taylor Tom Blickman Martin Jelsma Copy editor David Aronson Design Guido Jelsma www.guidojelsma.nl Photo credits Hash Marihuana & Hemp Museum, Amsterdam/ Barcelona Floris Leeuwenberg Pien Metaal UNOG Library/League of Nations Archives UN Photo Printing Jubels, Amsterdam Contact Transnational Institute (TNI) De Wittenstraat 25 1052 AK Amsterdam Netherlands Tel: +31-(0)20-6626608 Fax: +31-(0)20-6757176 [email protected] www.tni.org/drugs www.undrugcontrol.info www.druglawreform.info Global Drug Policy Observatory (GDPO) Research Institute for Arts and Humanities Rooms 201-202 James Callaghan Building Swansea University Financial contributions Singleton Park, Swansea SA2 8PP Tel: +44-(0)1792-604293 This report has been produced with the financial www.swansea.ac.uk/gdpo assistance of the Hash Marihuana & Hemp Museum, twitter: @gdpo_swan Amsterdam/Barcelona, the Open Society Foundations and the Drug Prevention and Information Programme This is an Open Access publication distributed under (DPIP) of the European Union. the terms of the Creative Commons Attribution License The contents of this publication are the sole responsibility (http://creativecommons.org/licenses/by/2.0), which of TNI and GDPO and can under no circumstances be permits unrestricted use, distribution, and reproduction regarded as reflecting the position of the donors. in any medium, provided the original work is properly cited. TNI would appreciate receiving a copy of the text in which this document is used or cited. -
Tratamiento Farmacológico De Dolor Neuropático De Tipo Central En Pacientes Con Esclerosis Múltiple1
TRATAMIENTO FARMACOLÓGICO DE DOLOR NEUROPÁTICO DE TIPO CENTRAL EN PACIENTES CON ESCLEROSIS MÚLTIPLE1 SYSTEMATIC REVIEW OF THE LITERATURE: PHARMACOLOGIC THERAPY IN CENTRAL NEUROPATHIC PAIN FOR MULTIPLE SCLEROSIS PATIENTS 2 Andrés Mauricio Álvarez Pinzón. 3 Janice Maldonado. Resumen Abstract La Esclerosis Múltiple es una enfermedad neurodesmie- Multiple sclerosis is an immunological disease that linizante de origen inmunológico que afecta a personas affects people between 16 and 40 years of age who entre los 16 a 40 años de edad quienes presentan como present central neuropathic pain more common as a síntoma asociado frecuente el dolor neuropático de tipo rate percentage 36% to 82% of MS patients. The neuro- central en un porcentaje del 36% al 82% de los pacientes. pathic pain syndromes dysfunction are evidenced by Dichos síndromes de dolor neuropático se evidencian por central nervous system dysfunction and injury to the disfunción del sistema nervioso central y lesión de las asas neural loops and myelin coating causing disability and neurales y su recubrimiento mielinico causando discapa- impaired quality of life of patients. cidad y deterioro de la calidad de vida de los pacientes. Objective: To evaluate the analgesic effectiveness with Objetivo: Evaluar la efectividad analgésica con menos fewer side effects of pharmacological treatments of efectos secundarios de los tratamientos farmacológicos Central Neuropathic pain in MS patients. de dolor neuropático en pacientes con Esclerosis Múltiple. Methodology: We performed a search strategy -
Religious Use of Drugs
Religious Use of Drugs Jay Leiderman Leiderman Devine LLP 5700 Ralston St #211 Ventura CA 93003 805 654 0200 www.leidermandevine.com [email protected] NORML PRESENTATION, Aspen, CO, 5 June 2011 IN THE BEGINNING . • And God said, Let the earth bring forth grass, and the herb yielding seed... -Genesis 1:11 I. FEDERAL LAW • “Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof . .” • It is the “free exercise clause” that is implicated by laws of general applicability that prohibit the religious use of drugs. I. FEDERAL LAW • The federal statute on religious use of drugs is the Religious Freedom Restoration Act (‘RFRA’). (42 U.S.C. § 2000bb et seq.) • RFRA provides that government, “shall not substantially burden a person’s exercise of religion even if the burden results from a rule of general applicability,” unless it passes the strict scrutiny test. I. FEDERAL LAW • The “RFRA is unconstitutional and does not trump California statutes prohibiting the sale or possession of marijuana for sale. ‘When the exercise of religion has been burdened in an incidental way by a law of general application, it does not follow that the persons affected have been burdened any more than other citizens, let alone burdened because of their religious beliefs.’ (City of Boerene v. Flores, (1997), 521 U.S. at p. 535 [138 L.Ed.2d at p. 648].)” I. FEDERAL LAW • The test applied to Federal Statutes and Federal Territories is the RFRA Test • The States revert to Employment Division v. Smith (1990) 494 U.S.